PTK7 increases activation of ERKs, JNK, and p38 in ESCC and vascular endothelial cells [8, 17], and decreases expression of BAX and cleavage of caspase-3, −8, and −9 in cholangiocarcinoma [15]. This evidence concerns the gene PTK7 and esophageal squamous cell carcinoma.